JIDE yields 4.39% · MRK yields 2.81%● Live data
📍 MRK pulled ahead of the other in Year 1
Combined, JIDE + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of JIDE + MRK for your $10,000?
JIDE is an actively managed fund focused on large- and mid-cap stocks in developed markets outside North America, such as Japan, Europe, and the UK. With holdings similar to those found in the MSCI EAFE Index, it is unconstrained by style or sector and may invest in securities denominated in major global currencies. Utilizing a core, best ideas portfolio, the adviser combines bottom-up fundamental analysis with data-driven insights, aiming to identify companies with positive fundamentals and improving outlooks at reasonable valuations. Environmental, social, and governance (ESG) factors are also considered during the investment process. The fund may use derivatives, primarily exchange-traded futures, and can adjust allocations by country, sector, or security type based on market conditions and outlook. Holdings may be sold if fundamentals deteriorate, valuations become unattractive, or better opportunities arise.
Full JIDE Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.